Home/Filings/4/0000905148-26-000034
4//SEC Filing

DUCHENE TODD M 4

Accession 0000905148-26-000034

CIK 0001839341other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 4:23 PM ET

Size

6.9 KB

Accession

0000905148-26-000034

Insider Transaction Report

Form 4
Period: 2025-12-31
DUCHENE TODD M
See remarks
Transactions
  • Award

    Common Stock

    2025-12-31+55,7582,077,880 total
  • Tax Payment

    Common Stock

    2025-12-31$15.08/sh139,873$2,109,2851,938,007 total
Footnotes (3)
  • [F1]Represents the acquisition of additional performance-based restricted stock units in connection with the 300% vesting of the second installment of the Reporting Person's performance-based restricted stock units granted on July 19, 2024, and previously reported at 100% vesting in the Form 4 filed by the Reporting Person on July 22, 2024.
  • [F2]Reported amount reflects the acquisition of 694 shares of Common Stock that the Reporting Person received on October 27, 2025 on an involuntary basis for no consideration in an in-kind distribution on a pro rata basis from a reserve of shares of Common Stock held for certain claims settlement matters in connection with previous bankruptcy proceedings of the Issuer, which was exempt from Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), pursuant to Rule 16a-9 under the Exchange Act.
  • [F3]Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units.

Documents

1 file

Issuer

Core Scientific, Inc./tx

CIK 0001839341

Entity typeother

Related Parties

1
  • filerCIK 0001248745

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:23 PM ET
Size
6.9 KB